Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Substance-Related Disorders × Dosage Forms × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Substance-Related Disorders 1 Pituitary Neoplasms 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Neurofibromatosis 1 1 Motor Activity 1 Lymphoma, Follicular 1 Lymphoma 1 Hematologic Neoplasms 1 Breast Neoplasms 1 Acromegaly 1

Interventions

Ultrasonic Waves 1 Therapeutics 1 Focus Groups 1 Ethanol 1 Educational Status 1 Dosage Forms 1 Cognitive Behavioral Therapy 1 Behavior Therapy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04345718 2025-12-09

EXHITENTRE

Hennepin Healthcare Research Institute

Phase 2/3 Completed

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡